Plastic recycling mainly refers to the procedure which is conducted either chemically or mechanically for recovering plastic waste from discarded products for the production of reusable plastic. The global market for plastic recycling has been rising at a steady rate over the last couple of years owing to the rising awareness among people regarding the high amount of carbon emissions and the need for reducing them. Plastic wastes have hazardous impact on the environment and thus the need of the hour for reducing emissions from them is at its peak. A lot of leading companies from different sectors are taking steps on reducing plastic waste through recycle and re-use. This is expected to not only help these companies to feature as an environment friendly brand, but also portray a positive image. Recently, Coca-Cola launched a sustainable packaging campaign with the aim of encouraging people to recycle plastic and other related waste. The campaign has been estimated to be a multi-million project.

Obtain Report Details @: http://www.transparencymarketresearch.com/plastic-recycling-market.html
Citing these, the global market for plastic recycling is expected to rise at a 6.9% CAGR from 2016 to 2024. In 2015, the market was worth US$31.5 bn and is anticipated to rise to a valuation of US$56.8 bn by the end of 2024.

In what manner will developing countries enable the market for plastic recycling to witness broad development?

The worldwide plastic recycling market is required to prosper over the up and coming years inferable from the strict position of created economies to diminish the disposing of plastic junks in landfills and furthermore put a restriction on plastics. The condition of swarming landfills has additionally provoked an essential requirement for reusing plastic as another option to make new material. In addition, the huge amount of raw petroleum obligatory to fabricate makes the assembling of virgin plastics fairly costly when contrasted with reusing plastics. Along these lines, minimal effort related with reusing plastics has likewise given the market the truly necessary boost.

Which viewpoint is probably going to pull back the advance of the market?

Despite the welfares of plastic reusing, the worldwide market is being confined back inferable from various reasons. To begin with, the shocking arrangement of social occasion squander materials is the essential impediment for the worldwide market. Around 10% of the aggregate waste created in Africa is diverted through the social affair frameworks. The rest 90% goes unaccounted for prompting expansion to landfills or being disposed of into waterway streams and seas.

Fill the form to gain deeper insights on this market @: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9049

Which district ought to be the key concentration of market players?

Asia Pacific is foreseen to command the worldwide market for plastic recycling over the conjecture time frame. China exclusively is required to contribute of more than half to the worldwide market. At present, Asia Pacific is the principle merchant region of plastic scraps utilized for reusing with India and China beating the diagrams. The area is brutally occupied with endeavors, for example, parings and changing the plastic waste into reused pitches for supplementary applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/plastic-recycling-market.html

ReleaseID: 8210

Global Genome Engineering Market: Snapshot

The field of genome engineering, the process of artificially introducing modification to the genetic content of an organism by introducing an artificially constructed piece of DNA of a specific composition into a recipient cell, has witnessed a significant rise in research activities in the past few years. Undertaken with the view of gaining larger clarity about the outcome of genome engineering experiments and finding newer applications of carefully controlled genetic experiments, the number of such research activities is rising at an immense pace.

Some of the most easily recognizable and highly popular applications of genome engineering practices are the use of genetically engineered microorganisms to produce vaccines and genetically modified crops. A vast variety of other applications of genome engineering are also being increasingly analyzed and put to use to develop organisms or living species with an improved genetic makeup.

Transparency Market Research estimates that the global genome engineering market will exhibit a remarkable 14.2% CAGR from 2015 through 2023, with market’s opportunity rising from US$2.30 bn in 2015 to an estimated US$7.21 bn by 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/genome-editing-engineering-market.html

Pharmaceutical and Biotechnology Companies Account for Massive Chunk in Market Revenues

Genome engineering practices find extensive usage across the academic field and industries such as agriculture, biotechnology, and pharmaceuticals. In 2014, biotechnology and pharmaceutical companies contributed nearly 58% of the market’s overall revenue. The significant rise in the use of genome engineering practices in therapeutics and drug discovery have contributed to the immense growth of this application segment. The trend is expected to remain strong over the report’s forecast period as well, with the extensive use of genome engineering in the pharmaceutical industry expected to drive the market significantly.

Applications of genome engineering in the academics sector emerged as the second largest contributor to the revenues of the global genome engineering market in 2014. Owing to the preliminary success achieved in a number of academic studies, the demand for genome engineering practices has significantly increased in the academic sector, chiefly for the production of mutants and treatment of genetic disorders. The vast global rise in prevalence of genetic disorders and a variety of cancers, the academic sector is expected to lead to stable demand for genome engineering practices in the next few years as well.

Vast Rise in Genome Research Activities to Help North America Retain Leading Position

Home to some of the world’s largest pharmaceutical and biotechnology companies, North America is one of the mist lucrative market’s for genome engineering. The region has witnessed a significant rise in research and development activities in the field of genetics and its applications across these industries. The North America genome engineering market held a valuation of US$1.27 bn in 2015 and is expected to continue to rise at a healthy pace over the report’s forecast period as well. The increasing demand for research dealing with the legal, ethical, and social implications of genome engineering will continue to lead to an increase in the number of genome engineering practices taking place in the region.

Over the report’s forecast period, Asia Pacific is expected to emerge as the most lucrative regional market for genome engineering. The regional market is expected to benefit from rising government incentives aimed at the development of the field in emerging economies and increased interest by companies in the region due to low research costs.

Some of the key vendors operating in the global genome engineering market profiled in the report are Thermo Fisher Scientific, Sigma-Aldrich Corporation, Integrated DNA Technologies, Inc., Sangamo Biosciences, Lonza Group Ltd., and Horizon Discovery Group Plc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4671

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com

ReleaseID: 8208

Global Disposable Syringes Market: Snapshot

The rapid increase in the number of injectable drugs to be approved recently has been a key contributor to the growth in demand for disposable syringes specifically, over other types of syringes. This is due to the growing number of patients afflicted with accidental needlestick injuries. Both factors thus work in tandem to create a staggering demand for disposable syringes and will continue to do so in the long term.

The number of disposable syringes being used has also increased due to the growth in point-of-care administration systems. These systems promote the self-administration of drugs, which can be easily done with modern disposable syringes with improved safety features.

The effective result of the above factors of influence on the market – along with a few others – for disposable syringes is expected to translate to a CAGR of 5.6% from 2015 to 2023. This market is expected to be valued above US$9.3 bn by the end of 2023 and close to US$6.5 bn by the end of 2016.

Obtain Report Details @
http://www.transparencymarketresearch.com/disposable-syringes-market.html

North America Remains Leading Disposable Syringe Consumer While Players Look to APAC for Bigger Opportunities

By the end of 2016, North America disposable syringe makers are expected to gain a revenue of US$3.9 bn, which is close to half of the total revenue earned on a global level. North America is expected to maintain its dominance over disposable syringes revenue till 2023, although it is expected to lose some percentage to the burgeoning Asia Pacific market. Europe will remain the second-largest region for disposable syringes till 2023. Both North America and Europe are showing a high demand for disposable syringes due to the growing number of injectable drugs in the market, improvements in syringe quality and safety through regulatory adherence, and the concern over a growing number of needlestick injuries.

China and India are expected to be the two key lucrative avenues for disposable syringes players in the near future, owing to their high population densities and growth in healthcare expenditures. A large part of this growth in demand for disposable syringes is attributed to the increasing number of government and private initiatives for conducting immunization drives across the countries. Additionally, the higher interest shown by North American and European players in these regions is expected to add to the quality of disposable syringes available in the market, further increasing their consumption rates.

Safety Syringes to Gain Larger Share

Conventional disposable syringes have held the larger share by volume till now, and will be expected to hold the dominant share for a few more years. However, the segment is expected to lose its leading position to safety syringes which are gaining popularity at a rapid pace. Safety syringes already lead the market in terms of value. By 2023, safety syringes are expected to hold a revenue share of 84%.

Key reasons for the high accelerated growth rate shown by safety syringes is the absence of any safety mechanisms in conventional ones. Safety syringes help protect patients from needlestick injuries and are just as accurate and easy to use as conventional disposable syringes.

The top manufacturers of disposable syringes in the world today include Becton, Dickinson & Company, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, Smiths Medical, and Retractable Technologies, Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1259

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com

ReleaseID: 8206

The global hybrid cars market is characterized by the prevalence of intense competition among the prominent vendors such as Volkswagen, BMW, Honda, Nissan, Ford, Hyundai, General Motors, and Toyota. A report by Transparency Market Research (TMR) estimates that this competition is further going to be magnified owing to the innovations by the leading market vendors. The companies are constantly trying to launch new products in manner to lead the competition. It is expected that companies with global presence and huge product portfolio will dominate the market in the coming future.

Obtain Report Details @: http://www.transparencymarketresearch.com/hybrid-cars-market.html

In the report, Transparency Market Research has estimated that the market will attain value of US$398.90 bn by 2024, and it was valued at US$102.88 bn in 2015. During the forecast period of 2016-2024, the global market for hybrid cars is expected to expand at a rising CAGR of 16.50%.

In 2015, Asia Pacific dominated the market and accounted for 70% of the global market. The increasing awareness among the consumers, especially in Japan and China is expected to help Asia-Pacific sustain it lead over the forecast period. Among series parallel hybrid cars, plug-in hybrid, parallel hybrid, and series hybrid; series parallel hybrid cars are expected to experience high demand and drive the global market.

Government Support for Low-Carbon Emitting Vehicles to Assist Market Growth

Consumers are adopting carbon-free products due to the alarming rise in the level of air pollution, which is continuously increasing the global temperature. Hybrid cars use electricity for their functioning instead of gasoline or diesel, helping to control carbon emission. This augmenting ecological awareness among consumers is expected to fuel the growth of the global market of hybrid cars.

Fill the form for an exclusive sample of this report @: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=250

Furthermore, governments in various countries have implemented strict rules to curb carbon emissions, which is motivating manufacturers to increase investment in the production of hybrid cars. Some governments are also providing various subsidies and incentives to buyers of hybrid cars, which is expected to fuel the demand for hybrid vehicles. For instance, for new passenger cars, the European Union norms of 2009 has set CO? emission level at 130g/km. The Euro VI norm introduced in 2014, suggests new cars to keep the nitrogen oxide emission below 0.4g/kWh and other emissions below 0.01g/kWh. Analysts forecast that the countries such as Brazil, Russia, Mexico, and Australia will also implement stringent emission standards in the near future, which is most likely to increase the global sale of hybrid cars.

High Cost of Hybrid Cars could Hamper Global Market Growth

Hybrid cars are very expensive, which may hinder the growth of the market during the forecast period. Furthermore, electric cars are suspected to be the direct competitor of hybrid cars. Easy availability of electric cars may act as a restraint for the growth of the global market of hybrid cars. Nevertheless, the implementation of stringent emission standards is expected to be in the favor of hybrid cars, which is expected to result in growth of hybrid cars global market. The hybrid cars are made up of lighter materials and have lighter engines, which make the car lighter, hence use less power for their functioning. As more consumers are adopting hybrid cars, these cars are started commanding higher resale values that traditional cars. This is motivating consumers to buy hybrid cars over traditional cars. The leading companies in this market are continuously spending on research and development practices of hybrid cars. These developments are expected to add an advantage for the growth of this market over the forecast period.

This information is taken from the report published by Transparency Market Research, “Hybrid Cars Market (Type – Series, Parallel, Plug-in, and Series-Parallel; Energy Source – ICE Hybrid, Fuel Cell Hybrid, Solar Hybrid, and Natural Gas Hybrid; Vehicle Type – Passenger Cars and Commercial Cars) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

For the report, the market has been segmented as follows:

By Type

Series hybrid
Parallel hybrid
Plug-in hybrid
Series-Parallel hybrid

By Energy Source

ICE hybrids
Fuel cell hybrids
Solar hybrid
Natural gas hybrid

By Vehicle Type

Passenger Cars
Commercial Car

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/hybrid-cars-market.html

ReleaseID: 8209

Primary Immunodeficiency Diseases Market: Key Insights

In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and 2023. Developed regions such as Europe and North America are predominantly contributing to the growth witnessed by this market. The consistent approval of novel therapeutic options for primary immunodeficiency diseases (PIDD) and extensive research and development investments by key players are likely to bolster opportunities for the market in the forthcoming years.

On the flip side, the absence of proper reimbursement and high cost of therapies will inhibit the market’s growth trajectory to an extent. Nevertheless, with favorable government policies and funding for research and development in biopharma and pharmaceuticals, growth prospects for the market seem quite promising.

TMR expects the global PIDD market to reach US$7.5 bn by the end of 2023, from a valuation of US$4.3 bn in 2014.

Obtain Report Details @
http://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html

Demand for PIDD Treatment Highest in North America and Europe

Collectively accounting for a share of 79.4% in the global PIDD market, North America and Europe emerged as the dominant regional segments in 2014. Among these regions, North America boasted the largest share of 56.2% in 2014, with the U.S. at the fore. As per TMR, the U.S. held over 80.2% of the PIDD market in North America in the same year. The nation is expected to continue demonstrating lucrative opportunities for the PIDD market through the forecast period.

Over the last couple of years, a persistently increasing prevalence of diseases such as selective IgA deficiency, IgG subclass deficiency, and common variable immune deficiency has been witnessed in North America. This has fuelled the uptake of PIDD therapeutics. However, the growing awareness pertaining to side-effects such as renal failure and allergic reactions frequently associated with the treatment could hamper the market’s growth to an extent.

The primary immunodeficiency diseases market in North America, which stood at US$2.4 bn in 2014, is expected to reach US$4.3 bn by the end of 2023. The market is therefore expected to rise at a CAGR of 6.4% during the period.

In Europe, the market is expected to gain from the increasing awareness regarding PIDD and favorable government support. The presence of companies such as Baxter International Inc., CSL Behring LLC, and Blotest Pharmaceuticals Corporation also supports the market’s expansion in the region. Apart from this, emerging nations in Asia Pacific also exhibit lucrative scope for the expansion of the PIDD market. The increasing willingness among people to spend on novel therapeutics augurs well for sales prospects of the market in Asia Pacific. The region currently holds only a moderate share in the market. However, in the near future the opportunities for sale of PIDD therapeutics in the region will increase considerably.

Rising Uptake of Immunoglobulin (Ig) Replacement Therapy Expected in Near Future

By treatment, stem cell and gene therapy, antibiotic therapy, immunoglobulin (Ig) replacement therapy, and others make the key segments in the global PIDD market. Of these, immunoglobulin replacement has been in use for the treatment of chronic ailments for the past two decades. Due to the recent developments, it is also used for the treatment of partial antibody deficiency and combined immunodeficiencies. The segment therefore emerged dominant in the market in 2014. As per TMR, immunoglobulin replacement therapy will hold on to its position as the market leader through the forecast period.

Despite, Ig replacement therapy being the most widely accepted treatment among PIDD patients, the use of antibiotics as an adjunct therapy is poised to surge in the near future. Some of the most commonly used antibiotics include penicillin, macrolides, cephalosporins, fluoroquinolones, and tetracyclines.

The demand for stem cell and gene therapy is also expected to increase during the forecast period, which in turn will augment the demand for effective PIDD treatment.

Some of the most prominent companies in the global primary immunodeficiency diseases market are CSL Behring LLC, Baxter International, Inc., Grifols S.A., Octapharma AG, and others.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com

ReleaseID: 8205

Led by several established players, such as America Cell Biobank Inc., CrioCenter, Banco de Cordon Umbilical (BCU), and Redcord S.A., the cord blood banking services market in Latin America has been demonstrating a highly competitive and fragmented business landscape, states a research study by Transparency Market Research (TMR). The market is characterized by various rules and policies that vary from country to country.

The market players are relying heavily on technical advancements for expansion in their businesses. CrioCenter, CordVida, Cellpreserve, CordCell, Redcord S.A., Cordón de Vida, Banco de Células Stem, and Células Madre C.A. are the other prominent cord blood banking service providers across Latin America, the report mentions.

A per the TMR’s report, the Latin America market for cord blood banking services was worth US$196.9 mn in 2014. Researchers project the market to proliferate at a CAGR of 9.40% over the period from 2015 to 2023 and attain a value of US$445.4 mn by the end of the forecast period.

Obtain Report Details @
http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html

Public Cord Blood Banking Services to Report Dominance

Currently, cord blood banking services are being discretely provided in the public and the private sectors, resulting in two types of storages, public and private, in this Latin American market. With continual funds from the governments, non-government organizations, and research societies, the public cord blood banking services segment has registered its dominance in this market. Analysts expect the scenario to remain so over the forecast period.

The research report also presents a comprehensive assessment of the Latin America market for cord blood banking services on the basis of its geographical bifurcation. Brazil, Columbia, Mexico, Argentina, and the Rest of Latin America have been considered as the main geographical segments of this regional market in this study. Brazil, Mexico, and Columbia have surfaced as the leading domestic markets for cord blood banking services in this region and are focusing aggressively on expanding the network of cord blood banks in Latin America.

Increasing Research Activities in Stem Cell Therapies to Boost Growth

“The market for cord blood banking services in Latin America has been gaining significant impetus from the advancements in the stem cell therapy research, thanks to the increasing infrastructural and technological progression in this region,” says a TMR analyst.

The high incidence rate of genetic disorders and quick and better treatment of such diseases, owing to the easy availability of advanced diagnostic services that provide accurate results are also supporting the growth of the Latin America cord blood banking services. However, the high charges for cord blood banking services and the common opinion among medical professionals about the less possibility of the usage of stored cord blood may limit the adoption of these services in a number of Latin American countries, such as Mexico, Brazil, Peru, and Argentina, reflecting negatively on the overall market, states the research report.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8413

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com

ReleaseID: 8207

The global dyslipidemia market is anticipated to witness a decline of -10.3%. CAGR between 2015 and 2023. The negative growth rate is a result of the expiration of blockbuster drugs that have allowed the introduction of several generic drugs, available at cheaper prices than branded drugs. Owing to this reason, the global market is expected to reach a valuation of US$6.88 bn by 2023 as compared to US$17.85 bn in 2014. However, the market also has several opportunities to gain from and reach a positive growth rate in the near future. For instance, the high prevalence of obesity due to poor dietary habits, lack of exercise, and changing lifestyles are expected to present a wide range growth opportunities for the overall market in the near future.

Obtain Report Details @
http://www.transparencymarketresearch.com/dyslipidemia-market.html

Diabetes and Obesity Give a New Lease of Life to Dyslipidemia Drugs Market

The rising cases of diabetes, especially the growing number of type 2 diabetics, have presented the global dyslipidemia market with a lucrative opportunity. Research indicates that diabetics are likely to suffer from lipid abnormalities that will lead to a higher uptake of dyslipidemia drugs in the near future. In a bid to solve the health issues of an exponentially growing patient pool, several companies are investing in intensive research and development in strengthening their pipelines and discovering newer treatment options. Furthermore, commercialization of new classes of drugs will also provide this market a push in the upward direction.

Europe Experiences Minimal Loss in Revenues due to Higher Spending Power of Patients

The Europe dyslipidemia drugs market is expected to witness a relatively low decline (at a CAGR of -9.9%) over the forecast period of 2015 and 2023. The losses in this regional market will be mitigated by the high incidence of dyslipidemia here. Furthermore, the ability of patients to afford dyslipidemia drugs and supportive reimbursement policies are also expected to keep losses in this market in check to some degree.

Favorable government policies are also expected to help the Europe dyslipidemia market in the near future. Rising healthcare expenditure by dyslipidemia patients in countries such as Germany, France, and the U.K. are also anticipated to create a lucrative growth for sustained growth of the market in the coming years. By the end of forecast period, the Europe dyslipidemia drugs market will reach US$1,802.8 mn by 2023.

Fibric Acid and Omega-3 Fatty Acid Derivatives Segment Leads Overall Market

Amongst the various type of drug classes, the fibric acid and omega-3 fatty acid derivatives segment will witness the least decline at a -1.6% CAGR between 2015 and 2023. A growing number of prescriptions for drugs such as Epanova, Vascespa, and Lovaza will be the primary reason why this segment will be able to mitigate its loss. The government approvals for fibric acid and omega-3 fatty acid derivatives class of drugs have also bolstered the demand for dyslipidemia drugs in recent years. The report suggests that Fenofibrate drugs are the popularly prescribed fibric acid and omega-3 fatty acid derived drugs to patients with dyslipidemia.

However, the future of this segment is on unsteady ground as these major drugs are expected to lose their patents. For instance, fenofibrate-containing drugs such as Trilipix, Antara, Tricor, and others will gradually lose importance to generic drugs.

Some of the leading players identified in this market are AstraZeneca plc., Merck & Co., Inc., Pfizer, Inc., Daiichi Sankyo Company, Limited, and Abbott Laboratories. The companies will continue to hold a strong presence due to their brand value and extensive goodwill in the market. Analysts state that new entrants must establish their foothold in the emerging market to profit from the large patient pool in developing countries of China and India and lower manufacturing costs.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1535

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8200

The global bulk container packaging market is driven by their use in the transportation of dry and free-flowing chemicals or materials. The growing exportation of vegetable oil from Southeast Asia is driving the growth of this market. Similarly the rise in the exportation of wine from Europe will fuel the demand for bulk container packaging. the low cost and high operational efficiency is a key reason behind the use of bulk container packaging such as tank containers, barrels, and drums. Use of flexitanks lowers the cost of glass and bottling and hence used for exporting wine. It also reduces the cost of import duties and overall transportation cost of wine. The growth of the global bulk container packaging is thus predicted to be a healthy one.

Obtain Report Details @: http://www.transparencymarketresearch.com/bulk-container-packaging-market.html#

Shale gas is produced in high quantities in the U.S. and this gas is used as a feedstock for the production of other chemicals. The abundance of low cost feedstock across the globe is attracting many investors towards the chemicals industry and this is anticipated to create specific packaging and transportation requirements for which bulk container packaging will suit perfectly, driving the growth prospects of this market in the years to come.

Cost Fluctuation of Raw Materials to Hamper Growth of Bulk Container Packaging Market

The volatility in the pricing of raw materials such as polyethylene and polypropylene, which are required for the manufacturing of flexitanks, bulk container lining, and FIBC will be a key factor hampering the growth of the bulk container packaging market. These raw materials also happen to be petrochemical derivatives and thus with the fluctuation of crude oil price, the cost of these materials also get influenced. This will also act as a challenge for market players. However, the growing commodity trade in BRICS nations will create potential growth opportunities for the bulk container packaging market.

Make an Enquiry @: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3829
Asia Pacific to Be Most Lucrative Market for Bulk Container Packaging in Future

Among regions such as Europe, Asia Pacific, North America, and the Rest of the World, it is estimated that Asia Pacific will most likely witness the fastest expansion or growth rate. The growth is attributed to the escalating exports of bulk chemicals and oils to Europe and North America. Europe is estimated to experience moderate growth in the bulk container packaging market. The high export of wines will be supporting the growth of this market in Europe. The Rest of the World (RoW) is anticipated to emerge as the second fastest expanding market for bulk container packaging on account of the increasing export of bulk chemicals and food products.

Chemical Segment to Continue to Retain Dominant Hold

By application, it is estimated that the chemical segment will continue to lead in the market but witness moderate growth in the forecast period. The demand for bulk container packaging in applications such as pharmaceuticals and others will grow at a sluggish pace. The food and beverage segment is estimated to emerge as the second largest segment to lead in the market in the years to come. The need to prevent contamination of food as well as maintain hygienic standards will drive the demand for bulk container packaging in the food and beverage sector. The increasing exports from Europe and Southeast Asia are another reason for the growth of this segment.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/bulk-container-packaging-market.html#

ReleaseID: 8203

Cryoablation is a treatment in which the irritated nerve is numbed by using localized freezing temperatures. Cryoablation is commonly known as cryosurgery, percutaneous cryoablation, or targeted cryoablation. It is the best treatment used in treating localized cancers, such as prostate cancer and skin cancer, and few abnormal skin cells. Cryoablation is used in treating conditions such as benign nerve growth which is neuromas, various forms of nerve entrapments, pre-cancerous skin nodules, skin tags, retinoblastoma, and liver and cervical cancer. In this treatment, a probe is inserted near the affected tissue and the temperature of the probe goes down effectively to freeze the nerve. The freezing process inactivates the nerve and thus the irritated nerve is relieved from pain. The current cryoablation treatment uses imaging guidance, a cryoprobe which is like a needle applicator, and liquid nitrogen or argon gas for intense freezing to destroy the abnormal cells.

Obtain Report Details @
http://www.transparencymarketresearch.com/cryoablation-device-market.html

The global cryoablation device market is expected to be a promising market during the forecast period. The market growth is driven majorly by factors such as innovation in surgery technologies, rising demand for advanced treatment therapy in developed countries, rising incidence of various types of cancer wherein target specific treatment is possible, and increasing prevalence of nerve diseases. In addition, increasing emphasis on minimally invasive surgery over the conventional method is an important factor for the market growth. According to the WHO, it is projected that cancer cases are expected to increase more than 70% by 2030. It is estimated that approximately 9 million deaths are due to various types of cancer. However, the treatment with cryoablation devices leaves the tissue affected with unusual sensations such as numbness, tingling, and irritation of the skin, which is one of the restraining factors for the market growth.

The global cryoablation device market is segmented according to device, application, end-user, and region. In terms of device, the market is segmented into tissue contact probe ablators, epidermal and subcutaneous cryoablation systems, and tissue spray probe ablators. In terms of application, the market is segmented into oncology, dermatology, cardiology, pain management, ophthalmology, and gynecology. In terms of end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and research institutes.

Geographically, the global cryoablation device market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the cryoablation device market due to well-developed health care infrastructure and availability of advanced medical technology and skilled professionals. These are the factors driving the market growth for cryoablation device. Europe is the second largest market for cryoablation devices. Use of advanced medical technology and well-developed health care infrastructure along with increasing awareness about different treatment options are factors boosting the growth of the Europe cryoablation device market. Asia Pacific is expected to project a fast growth rate during the forecast period due to increasing awareness about different treatment options and fast growing economies such as India and China. Latin America is an emerging market for cryoablation treatment and is expected to expand at a significant growth rate due to increasing awareness and improving economic conditions. Middle East & Africa is likely to be a promising market due to slow economic growth and high cost incurred in the treatment.

Key players operating in the global cryoablation device market include CryoConcepts LP, Brymill Cryogenic Systems, Metrum Cryoflex, CooperSurgical, Inc., Cortex Technology, Cryoalfa, Erbe Elektromedizin, GmbH, Galil Medical, Inc., Medtronic Inc., Boston Scientific Corporation, AtriCure, Inc., Smith & Nephew plc., Varian Medical Systems, Inc., Integra LifeSciences Holdings Corporation, Terumo Corporation, and Johnson & Johnson.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26828

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com

ReleaseID: 8194

The global 2-shot injection molding market has been prognosticated to demonstrate a vastly fragmented character. This could be on account of a substantial number of industry players operating in the market. A report prepared by Transparency Market Research (TMR) has envisaged a stiff competition to take shape in the market, owing to a small share held by each player.

Obtain Report Details @: http://www.transparencymarketresearch.com/2-shot-injection-molding-market.html

By the end of 2024, the global 2-shot injection molding market could arrive at a valuation of around US$11.5 bn from US$6.6 bn in 2015, according to TMR. Between 2016 and 2024, the market could expand at a 6.5% CAGR. As per application analysis, the medical market for 2-shot injection molding has been envisioned to rise with an approximate 25.8% share by the concluding forecast year after having acquired a dominant share in 2015. Geographically, Europe could be at the helm of the market with a 33.9% share expected to be achieved by the same year.

Among top players, Gemini Group, Inc., Paragon Rapid Technologies Limited, Nyloncraft, Inc., and Rogan Corporation could secure a leading position in the global 2-shot injection molding market. As per the analysis of the report’s lead author, players have been projected to take to improving their production volume for staying relevant in the market. Moreover, there could a high focus on shortening the lead time to showcase competitiveness.

Accurate Repeatability, Precise Production Using Single Tool Enhance Adoption

The production of remarkably precise parts could be ensured with the implementation of 2-shot injection molding warranting exact repeatability using merely a single tool. With this advantage in view, 2-shot injection molding could prove to be vital for encouraging original equipment manufacturers (OEMs) to design and develop an increasingly more count of products. As a result, there could be an augmenting adoption of the process across the world. The growth of the world 2-shot injection molding market has been forecasted to be boosted significantly on the back of another advantage, i.e. cost reduction. This could be achieved with execution of a single operation for producing two component parts.

Fill the form to gain deeper insights on this market @: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18512

Expensive Equipment Cost, Initial Investments Dampen Demand

One of the main impediments of growth in the international 2-shot injection molding market has been anticipated to be the exorbitant cost of tools and equipment in comparison with that of those used in conventional molding. Furthermore, manufacturers could be discouraged to adopt 2-shot injection molding in their production processes due to considerably extortionate initial investment costs. The restricted choices of material pairs that could be used for 2-shot injection molding have been predicted to stymie the market.

However, the analysts have expected some unswerving prospects to show face in the international 2-shot injection molding market. These could be in the form of rising government pressure to recycle plastics. OEMs could be encouraged to increase the adoption of 2-shot injection molding as tight government regulations compel industries to recycle materials. A chief advantage of implementing 2-shot injection molding is that the core of any two component parts could be derived from recycled plastic while doing away with any change in its property or appearance. In this regard, the elevating uptake of recycled plastic has been prophesied to bode well for the market.

The global 2-shot injection molding market has been segmented as presented below:

Global 2-shot Injection Molding Market – Product Analysis

Polypropylene
Polycarbonate
Acrylonitrile Butadiene Styrene (ABS)
Polystyrene
Plastics (Nylon and PBT)
Silicones
Styrene Butadiene Rubber (SBR)
Thermoplastic Elastomers (TPE)
Elastomers (Nitrile Rubber and Natural Rubber)

Global 2-shot Injection Molding Market – Application Analysis

Medical
Automotive
Consumer Goods
Electrical and Electronics
Industrial
Packaging

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/2-shot-injection-molding-market.html

ReleaseID: 8199